Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

Wan‐Teck Lim(National Cancer Centre Singapore), N. Gopalakrishna Iyer(Duke-NUS Medical School)
Nature Communications
May 15, 2023
Cited by 46


Related Papers